These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 8616600)
1. A comparison of the effects of a sodium channel blocker and an NMDA antagonist upon extracellular glutamate in rat focal cerebral ischemia. Chen J; Graham SH; Simon RP Brain Res; 1995 Nov; 699(1):121-4. PubMed ID: 8616600 [TBL] [Abstract][Full Text] [Related]
2. A use-dependent sodium channel antagonist, 619C89, in reduction of ischemic brain damage and glutamate release after acute subdural hematoma in the rat. Tsuchida E; Harms JF; Woodward JJ; Bullock R J Neurosurg; 1996 Jul; 85(1):104-11. PubMed ID: 8683258 [TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effects of a use-dependent blocker of voltage-dependent sodium channels, BW619C89, in rat middle cerebral artery occlusion. Graham SH; Chen J; Lan J; Leach MJ; Simon RP J Pharmacol Exp Ther; 1994 May; 269(2):854-9. PubMed ID: 7910213 [TBL] [Abstract][Full Text] [Related]
4. Blockers of NMDA-operated channels decrease glutamate and aspartate extracellular accumulation in striatum during forebrain ischaemia in rats. Ghribi O; Callebert J; Verrecchia C; Plotkine M; Boulu RG Fundam Clin Pharmacol; 1995; 9(2):141-6. PubMed ID: 7628826 [TBL] [Abstract][Full Text] [Related]
6. Diethylmaleate decreased ascorbic acid release induced by cerebral ischemia in cerebral cortex of the anesthetized rat. Yang CS; Tsai PJ; Lin NN; Kuo JS Chin J Physiol; 2000 Jun; 43(2):49-53. PubMed ID: 10994693 [TBL] [Abstract][Full Text] [Related]
7. Effects of AMPA-receptor and voltage-sensitive sodium channel blockade on high potassium-induced glutamate release and neuronal death in vivo. Wu A; Fujikawa DG Brain Res; 2002 Aug; 946(1):119-29. PubMed ID: 12133601 [TBL] [Abstract][Full Text] [Related]
8. Isradipine, a calcium channel blocker, attenuates the ischemia-induced release of dopamine but not glutamate in rats. Nakane H; Ooboshi H; Ibayashi S; Yao H; Sadoshima S; Fujishima M Neurosci Lett; 1995 Mar; 188(3):151-4. PubMed ID: 7609897 [TBL] [Abstract][Full Text] [Related]
9. Glutamate preconditioning prevents neuronal death induced by combined oxygen-glucose deprivation in cultured cortical neurons. Lin CH; Chen PS; Gean PW Eur J Pharmacol; 2008 Jul; 589(1-3):85-93. PubMed ID: 18589412 [TBL] [Abstract][Full Text] [Related]
10. Neurotensin regulates cortical glutamate transmission by modulating N-methyl-D-aspartate receptor functional activity: an in vivo microdialysis study. Ferraro L; Beggiato S; Tomasini MC; Fuxe K; Tanganelli S; Antonelli T J Neurosci Res; 2011 Oct; 89(10):1618-26. PubMed ID: 21656844 [TBL] [Abstract][Full Text] [Related]
11. Effects of combined glutamate and platelet-activating factor inhibition on the outcome of focal cerebral ischaemia - an initial screening study. Aspey BS; Alp MS; Patel Y; Harrison MJ Metab Brain Dis; 1997 Sep; 12(3):237-49. PubMed ID: 9346472 [TBL] [Abstract][Full Text] [Related]
12. Potassium channel opener reduces extracellular glutamate concentration in rat focal cerebral ischemia. Fujita H; Takizawa S; Nanri K; Matsushima K; Ogawa S; Shinohara Y Brain Res Bull; 1997; 43(4):365-8. PubMed ID: 9241438 [TBL] [Abstract][Full Text] [Related]
13. Cerebroside-A provides potent neuroprotection after cerebral ischaemia through reducing glutamate release and Ca²⁺ influx of NMDA receptors. Li L; Yang R; Sun K; Bai Y; Zhang Z; Zhou L; Qi Z; Qi J; Chen L Int J Neuropsychopharmacol; 2012 May; 15(4):497-507. PubMed ID: 21557879 [TBL] [Abstract][Full Text] [Related]
15. Nuclear factor kappaB activation is mediated by NMDA and non-NMDA receptor and L-type voltage-gated Ca(2+) channel following severe global ischemia in rat hippocampus. Shen W; Zhang C; Zhang G Brain Res; 2002 Apr; 933(1):23-30. PubMed ID: 11929632 [TBL] [Abstract][Full Text] [Related]
16. Relationship between extracellular glutamate concentration and voltage-sensitive calcium channel function in focal cerebral ischemia in the rat. Osuga H; Hakim AM J Cereb Blood Flow Metab; 1996 Jul; 16(4):629-36. PubMed ID: 8964802 [TBL] [Abstract][Full Text] [Related]
17. Transporter reversal as a mechanism of glutamate release from the ischemic rat cerebral cortex: studies with DL-threo-beta-benzyloxyaspartate. Phillis JW; Ren J; O'Regan MH Brain Res; 2000 Jun; 868(1):105-12. PubMed ID: 10841893 [TBL] [Abstract][Full Text] [Related]
18. The role of glutamate in epilepsy and other CNS disorders. Meldrum BS Neurology; 1994 Nov; 44(11 Suppl 8):S14-23. PubMed ID: 7970002 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of evoked glutamate release by the neuroprotective 5-HT(1A) receptor agonist BAY x 3702 in vitro and in vivo. Mauler F; Fahrig T; Horváth E; Jork R Brain Res; 2001 Jan; 888(1):150-157. PubMed ID: 11146061 [TBL] [Abstract][Full Text] [Related]
20. NMDA-induced glutamate and aspartate release from rat cortical pyramidal neurones: evidence for modulation by a 5-HT1A antagonist. Dijk SN; Francis PT; Stratmann GC; Bowen DM Br J Pharmacol; 1995 Aug; 115(7):1169-74. PubMed ID: 7582540 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]